Article
The growth and metastasis of human, HER-2/neu-overexpressing tumor cell lines in male SCID mice.
Breast cancer research and treatment - 1 Jun 2000
Clinchy B, Gazdar A, Rabinovsky R, Yefenof E, Gordon B, Vitetta E S
Abstract excerpt
HER-2/neu is overexpressed on a variety of human adenocarcinomas and overexpression has been associated with a poor prognosis. For this reason, HER-2 has become an attractive target for immunotherapy. To facilitate testing of anti-HER-2-monoclonal antibodies (MAbs) and immunotoxins (ITs), we have evaluated the in vivo growth and metastatic spread of three HER-2-overexpressing human breast cancer cell lines...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
